OPTIVUS TECHNOLOGY, INC. – Trademark Portfolio

Entity Type: 03

OPTIVUS TECHNOLOGY, INC. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 4 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include OPTIVUS. The owner is based in SAN BERNARDINO, CA.

1260 EAST VICTORIA AVENUE

SAN BERNARDINO, CA 92408

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

OPTIVUS TECHNOLOGY, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (4 filings)

Surgical, medical, dental and veterinary apparatus and instruments

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does OPTIVUS TECHNOLOGY, INC. have?

OPTIVUS TECHNOLOGY, INC. has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 4 cancelled.

What trademark classes does OPTIVUS TECHNOLOGY, INC. file in?

OPTIVUS TECHNOLOGY, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are OPTIVUS TECHNOLOGY, INC.'s most well-known trademarks?

OPTIVUS TECHNOLOGY, INC.'s registered trademark portfolio includes well-known marks such as OPTIVUS. These are among 1 currently registered trademark in the portfolio.

What is OPTIVUS TECHNOLOGY, INC.'s trademark registration success rate?

OPTIVUS TECHNOLOGY, INC. has a 17% trademark registration rate, with 1 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.